214 related articles for article (PubMed ID: 36808002)
1. Predictive value of
Chen K; Wang J; Li S; Zhou W; Xu W
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):1869-1880. PubMed ID: 36808002
[TBL] [Abstract][Full Text] [Related]
2.
Li P; Wang X; Xu C; Liu C; Zheng C; Fulham MJ; Feng D; Wang L; Song S; Huang G
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1116-1126. PubMed ID: 31982990
[TBL] [Abstract][Full Text] [Related]
3. Intra and peritumoral PET radiomics analysis to predict the pathological response in breast cancer patients receiving neoadjuvant chemotherapy.
Aksu A; Güç ZG; Küçüker KA; Alacacıoğlu A; Turgut B
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2024; 43(3):500002. PubMed ID: 38527731
[TBL] [Abstract][Full Text] [Related]
4. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
[TBL] [Abstract][Full Text] [Related]
5. Subtype-Guided
Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
[TBL] [Abstract][Full Text] [Related]
6. [
Ferreira M; Lovinfosse P; Hermesse J; Decuypere M; Rousseau C; Lucia F; Schick U; Reinhold C; Robin P; Hatt M; Visvikis D; Bernard C; Leijenaar RTH; Kridelka F; Lambin P; Meyer PE; Hustinx R
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3432-3443. PubMed ID: 33772334
[TBL] [Abstract][Full Text] [Related]
7. PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.
Antunovic L; De Sanctis R; Cozzi L; Kirienko M; Sagona A; Torrisi R; Tinterri C; Santoro A; Chiti A; Zelic R; Sollini M
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1468-1477. PubMed ID: 30915523
[TBL] [Abstract][Full Text] [Related]
8. Combination of breast imaging parameters obtained from
Grapin M; Coutant C; Riedinger JM; Ladoire S; Brunotte F; Cochet A; Humbert O
Eur J Radiol; 2019 Apr; 113():81-88. PubMed ID: 30927964
[TBL] [Abstract][Full Text] [Related]
9. Textural features of
Cheng L; Zhang J; Wang Y; Xu X; Zhang Y; Zhang Y; Liu G; Cheng J
Ann Nucl Med; 2017 Aug; 31(7):544-552. PubMed ID: 28646331
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtype classification of breast cancer using established radiomic signature models based on
Liu J; Bian H; Zhang Y; Gao Y; Yin G; Wang Z; Li X; Ma W; Xu W
Front Biosci (Landmark Ed); 2021 Aug; 26(9):475-484. PubMed ID: 34590460
[No Abstract] [Full Text] [Related]
11. The Value of 18F-FDG PET/CT Imaging Combined With Pretherapeutic Ki67 for Early Prediction of Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer.
Luo J; Zhou Z; Yang Z; Chen X; Cheng J; Shao Z; Guo X; Tuan J; Fu X; Yu X
Medicine (Baltimore); 2016 Feb; 95(8):e2914. PubMed ID: 26937935
[TBL] [Abstract][Full Text] [Related]
12. Can FDG-PET/CT predict early response to neoadjuvant chemotherapy in breast cancer?
Andrade WP; Lima EN; Osório CA; do Socorro Maciel M; Baiocchi G; Bitencourt AG; Fanelli MF; Damascena AS; Soares FA
Eur J Surg Oncol; 2013 Dec; 39(12):1358-63. PubMed ID: 24120422
[TBL] [Abstract][Full Text] [Related]
13. The value of pre- and post-neoadjuvant chemotherapy F-18 FDG PET/CT scans in breast cancer: comparison with MRI.
Choi EK; Yoo IR; Kim SH; Park SY; O JH; Kang BJ
Acta Radiol; 2018 Jan; 59(1):41-49. PubMed ID: 28427271
[TBL] [Abstract][Full Text] [Related]
14. Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
Ueda S; Yoshizawa N; Shigekawa T; Takeuchi H; Ogura H; Osaki A; Saeki T; Ueda Y; Yamane T; Kuji I; Sakahara H
J Nucl Med; 2016 Aug; 57(8):1189-95. PubMed ID: 26940765
[TBL] [Abstract][Full Text] [Related]
15. The accuracy of
Tian F; Shen G; Deng Y; Diao W; Jia Z
Eur Radiol; 2017 Nov; 27(11):4786-4796. PubMed ID: 28477166
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers from in vivo molecular imaging of breast cancer: pretreatment
Gallivanone F; Panzeri MM; Canevari C; Losio C; Gianolli L; De Cobelli F; Castiglioni I
MAGMA; 2017 Aug; 30(4):359-373. PubMed ID: 28246950
[TBL] [Abstract][Full Text] [Related]
17. Radiomics based on
Ou X; Zhang J; Wang J; Pang F; Wang Y; Wei X; Ma X
Cancer Med; 2020 Jan; 9(2):496-506. PubMed ID: 31769230
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment CT and
Rishi A; Zhang GG; Yuan Z; Sim AJ; Song EY; Moros EG; Tomaszewski MR; Latifi K; Pimiento JM; Fontaine JP; Mehta R; Harrison LB; Hoffe SE; Frakes JM
J Med Imaging Radiat Oncol; 2021 Feb; 65(1):102-111. PubMed ID: 33258556
[TBL] [Abstract][Full Text] [Related]
19. 18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer.
Cheng J; Wang Y; Mo M; Bao X; Zhang Y; Liu G; Zhang J; Geng D
Oncotarget; 2015 Oct; 6(30):29388-95. PubMed ID: 26336821
[TBL] [Abstract][Full Text] [Related]
20. Utility of
Lee IH; Lee SJ; Lee J; Jung JH; Park HY; Jeong SY; Lee SW; Chae YS
BMC Cancer; 2020 Nov; 20(1):1106. PubMed ID: 33198673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]